Index Detail:BSE OIL & GAS
MUMBAI - Indian drugmaker Ranbaxy Laboratories Ltd , reeling under a flurry of regulatory rebukes due to manufacturing quality concerns, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.
|MCX GOLD c1||Rs30,143.00||Rs-66.00|
|MCX SILVER c1||Rs46,136.00||Rs-421.00|
|BRENT CRUDE JUL1||$108.75||$0.65|